Page 6 of 6 
I understand that if I have further questions, comments, or concerns about the study or 
the informed consent process, I may write or call the office of the Vice Chancellor-Research 
Programs, 3134 Murphy Hall, UCLA, Los Angeles, CA 90024, (310) 825-8714. 
In signing this consent form, I acknowledge receiving a copy of the form as well as a 
copy of the Subjects’ Bill of Rights. 
Treatme nt, Te st, Bi opsy and Follow-up Schedule: 
One m onth before treatment: re moval of portion of tumor, draw blood (1/6 cup) 
treatment weeks 1-4: receive TIL and PBL on day 1; IL-2 on M,T,W,Th,F by vein; 
optional tumor biopsies on weeks 1,2,3; weekly blood draws (1/12 
cup); weekly clinic visits. 
trea tment weeks 7-10, 
13-16, 19-22 : receive IL-2 on M,T,W,Th,F by vein, weekly blood draws, 
weekly clinic visits. 
Date 
Signature of Patient 
Time 
Signature of Witness 
HSPC #91-10-442 
Date of expiration 
Recombinant DNA Research, Volume 15 
[553] 
